When choosing a functional service consulting and recruiting for your CRO, the intangibles make the difference

​

Many CROs can get you from Phase I clinical trials to FDA approval. But it's the journey, rather than the destination, that should determine your slection.

ReachCatalyst is an award-winning, global Contract Research Organization (CRO) focused primarily in oncology, vaccines, and general medicine. Reach Catalyst provides a full complement of clinical services for the pharmaceutical and biotech industries including the management and implementation of Phase I-IV clinical trials.

​

Reach Catalyst has been honored as a Best CRO partner Award nominee by industry leaders 11 consecutive years, after being evaluated against global CROs for quality of services, performance, client satisfaction, Sponsor relationships, and the overall value brought to study Sponsors. Additionally, in 2020, Reach Catalyst was named a winner of the 2020 CRO Leadership Award for Overall Compatibility servicing a combination of both large and small pharma and biotech clientele. Presented by Life Science Leader and Clinical Leader, the Awards evaluated over 60 contract research organizations on more than 20 performance metrics in ISR’s annual CRO Quality Benchmarking survey.

​

Reach Catalyst is known within the industry for its experience in managing clinical trials, for successful clinical oversight with a quality focus, patient enrollment and retention, and for providing full-service solutions to Sponsors. Our ability to quickly adapt to any challenges makes us an industry standout. Clients were extremely satisfied with our rapid response and implementation of our Business Continuity Plan to diminish the impact of COVID-19 on our projects. Our team of dedicated research professionals readily define, embrace and implement new processes while maintaining quality and safety standards. Satisfied Sponsors and repeat business are a testament to the effectiveness of our approach.